Grants for State Governments

This funding opportunity provides financial support to state and local governments, public utilities, and agencies for the procurement and use of low-carbon products made from captured carbon emissions, promoting sustainable practices and environmental benefits.

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R21 grant mechanism, while RFA-MH-25-185 uses the R01 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.

With this solicitation, OJJDP seeks to provide support to CACs through a variety of subgrant assistance designed to enhance effective interventions in child abuse cases. CACs provide a coordinated response to child abuse victims through multidisciplinary teams composed of representatives from the agencies involved in the intervention, prevention, prosecution, and investigation systems that respond to child abuse.

The DOD Pancreatic Cancer, Idea Development Award is a grant that funds innovative, high-risk/high-reward research projects with the potential to significantly advance our understanding of pancreatic cancer and improve patient outcomes, with a special focus on supporting early-career investigators in the field.

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R01 grant mechanism, while RFA-MH-25-186 uses the R21 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.

Announces the availability of $500,000,000 for FY 2024 Port Infrastructure Development Program grants.

Pursuant to 42 U.S.C. Section 5135, FEMA will provide grants to capitalize revolving loan funds which may be used to provide loans to finance various types of hazard mitigation projects to reduce risks from natural hazards and disasters. Through the Safeguarding Tomorrow through Ongoing Risk Mitigation Revolving Loan Fund (Safeguarding Tomorrow RLF)program, eligible entities (refer to Section C.1) will use these capitalization grants to establish a revolving loan fund (referred to herein as an entity loan fund) from which they will provide direct loans to local governments for projects and activities that mitigate the impacts of drought, intense heat, severe storms (including hurricanes, tornadoes, windstorms, cyclones, and severe winter storms), wildfires, floods, earthquakes, and other natural hazards. Eligible activities may include the construction or modification of natural or built infrastructure to increase resilience and reduce risk of harm. Entity loan funds will be programmatically and financially administered by the respective entity. FEMA will monitor the administration of the entity loan funds during the period of performance per the reporting requirements, and will continue to monitor administration of the entity loan funds after the capitalization grant closeout via biennial audits and post-closeout reporting. Under 42 U.S.C. ? 5135(h)(3)(C), FEMA may make recommendations for or require specific changes as needed to improve the effectiveness of the funds. Funding for the Safeguarding Tomorrow RLF program is limited. Pursuant to the Infrastructure Investment and Jobs Act, also more commonly known as the Bipartisan Infrastructure Law (BIL), FEMA must award funding through multiple Notices of Funding Opportunity over a 5-year period. The Safeguarding Tomorrow RLF program aligns with the goal of promoting resilience and adaptation in light of current risks, including those posed by climate change, and the 2020-2024 DHS Strategic Plan (https://www.dhs.gov/publication/department-homeland-securitys-strategic-plan-fiscal-years-2020-2024) through Goal 5: Strengthen Preparedness and Resilience. Specifically, Objective 5.1: Build a National Culture of Preparedness has several sub-objectives that the Safeguarding Tomorrow RLF program supports. The Safeguarding Tomorrow RLF program serves primarily to bolster Sub-Objective 5.1.1: Incentivize investments that reduce risk and increase pre-disaster mitigation, including expanding the use of insurance to manage risk through funding hazard mitigation projects, particularly ones that reduce risk to infrastructure. By focusing on increasing resilience and reducing harm to built infrastructure, this program will help members of underserved communities,1 who might be at heightened risk as a result of current hazards, including those associated with climate change. The Safeguarding Tomorrow RLF program complements and supplements FEMA's Hazard Mitigation Assistance (HMA) grant portfolio to support mitigation projects at the local government level and increase the Nation's resilience to natural hazards and climate change. Entity loan funds can be leveraged differently than other funding opportunities to meet unique funding needs. This program will support entity-led hazard mitigation priorities and allow participating entities to meet their funding needs as described in the entity's Intended Use Plan (see Section D.10.b). Such needs may include but are not limited to: meeting non-Federal cost-share requirements for other grants, upfront project design costs, smaller projects that may not qualify for other HMA grant programs, or projects that do not meet the cost-effectiveness requirements applicable for other programs.

This grant provides funding to state and local governments in Montana for professional services to develop projects that conserve and manage the state's renewable resources.

This award mechanism seeks to support the delivery of evidence-based clinical services to screen for cancer and pre-cancer in underserved populations who do not have adequate access to cancer early detection interventions and health care, bringing together networks of public health and community partners to carry out programs tailored for their communities. Projects should identify cancers that cause the most burden in the community, have nationally recommended screening methods, and use evidence-based methods to screen for these cancers. Award: Maximum of $1M for new projects and $2.5M for expansion projects Duration: Maximum 5 years

The "Coordinating Center for Type 1 Diabetes TrialNet" grant aims to fund the TrialNet Coordinating Center, which conducts research, trials, and studies to prevent the progression of type 1 diabetes and preserve insulin production, while also managing data, samples, and network operations, and promoting diverse perspectives in its work.

The purpose of the Maternal and Child Health Policy Innovation Program (MCH PIP) is to support innovative city, county, or state-level policy initiatives that improve outcomes and reduce associated health disparities for maternal and child health populations. Successful award recipients will provide technical assistance (TA) to stakeholders4, including governors offices, state legislatures, state and local health officials, and other state and local officials5 to help them develop and implement policy initiatives that improve outcomes and reduce related health disparities. Technical assistance will include (1) convening learning communities (LCs) that engage stakeholders (listed above) in addition to community members and people with lived experience and (2) developing and disseminating informational resources such as (but not limited to) policy briefs, webinars, and/or legislation trackers. Technical assistance for policy initiatives that address social determinants of health6 (SDOH), such as improving access to quality affordable housing, healthy foods, or transportation, is especially encouraged. Award recipients will also support TA for cities, counties, and/or states on Maternal and Child Health Bureau (MCHB) priority topics such as maternal and infant mortality and readiness for obstetric emergencies, and emerging MCH issues (recent examples of which include congenital syphilis, environmental health threats, Medicaid redetermination, and vaccine promotion).

This grant provides long-term funding to experienced researchers in heart, lung, blood, and sleep studies, allowing them the flexibility to pursue innovative and high-risk research programs.

This funding opportunity provides mid-career clinician-scientists with financial support and protected time to conduct patient-oriented research and mentor junior investigators in basic science studies involving human participants.

The purpose of this Notice of Funding Opportunity (NOFO) is to address the needs of the maternal and pediatric HIV scientific community for research data translation and sharing. This initiative will support secondary data analyses using archived HIV/AIDS data and specimens to generate new research questions and findings relevant to the scientific mission and priorities of the NICHD, Maternal and Pediatric Infectious Disease Branch (MPIDB) and Office of AIDS Research (OAR). The goal of this initiative is to encourage applicants to leverage existing datasets and employ new and advanced analysis techniques to answer scientific questions about the epidemiology, pathogenesis, treatment, clinical manifestations and complications of HIV/AIDS in maternal, pediatric and adolescent populations.

This funding opportunity supports new entrepreneurs in small businesses by providing resources for their career development and research efforts, helping them grow their skills in technology and healthcare innovation.

This grant provides funding to mid-career clinicians to focus on patient-oriented research and mentor junior researchers, allowing them to dedicate a portion of their time to advancing clinical studies and developing new investigators in the field.

To obtain a copy of the Funding Opportunity Announcement (FOA) please go to the ARPA-E website at https://arpa-e-foa.energy.gov. To apply to this FOA, Applicants must register with and submit application materials through ARPA-E eXCHANGE (https://arpa-e-foa.energy.gov/Registration.aspx). For detailed guidance on using ARPA-E eXCHANGE, please refer to the ARPA-E eXCHANGE User Guide (https://arpa-e-foa.energy.gov/Manuals.aspx). ARPA-E will not review or consider concept papers submitted through other means. For problems with ARPA-E eXCHANGE, email ExchangeHelp@hq.doe.gov (with FOA name and number in the subject line). Questions about this FOA? Check the Frequently Asked Questions available at http://arpa-e.energy.gov/faq. For questions that have not already been answered, email ARPA-E-CO@hq.doe.gov. The purpose of this modification is to incorporate changes to Funding Opportunity Announcement. Accordingly, this modification: Inserted new Exploratory Topic, Topic M: H2SENSE. See Table 1. Exploratory Topics, Appendix M, and Total Amounts to be awarded on Cover Page. Updated Language in Appendix L Section 5.

This grant provides long-term funding to experienced researchers in heart, lung, blood, and sleep studies, allowing them the flexibility to pursue innovative and ambitious research projects without the constraints of traditional grant applications.

This notice announces the opportunity to apply for funding under the Center for Maternal and Child Health Medicaid Partnerships program. The purpose of the Center for Maternal and Child Health Medicaid Partnerships is to strengthen collaboration between state Medicaid, Childrens Health Insurance Program (CHIP), and Title V Maternal and Child Health Services Block Grant (Title V) programs and advance innovative financing strategies that improve outcomes and reduce health disparities for maternal and child health (MCH) populations. The award recipient will build knowledge and shared priorities between state Medicaid, CHIP, and Title V programs and provide one-to-one, state-specific tailored capacity-building assistance directly to state Medicaid, CHIP, and Title V programs to support MCH. Support will include: (1) engaging state Title V, Medicaid, and CHIP programs to identify shared priorities and foster a common understanding of needs, opportunities, and best practices; (2) one-to-one, state-specific, tailored assistance to advance MCH financing; (3) support the development of innovative collaborative models leveraging HRSA, CHIP, and Medicaid funding, and (4) one-to-one capacity-building assistance to advance interagency agreements required by statute.

This grant provides financial support and dedicated research time for early-career scientists conducting basic experimental studies involving human participants, helping them advance their research careers.